The first evidence that linked NF-kB pathway activation and HCC development was from a mouse model of chronic liver inflammation in which NF-kB activation in non-parenchymal cells contributed to the tumor burden [175]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.